DCGO - DocGo Inc. Stock Price, Fair Value and News

3.52USD+0.02 (+0.57%)Market Closed

Market Summary

USD3.52+0.02

Market Closed

0.57%

DCGO Alerts

2 major insider buys recently.

DCGO Stock Price

View Fullscreen

DCGO RSI Chart

DCGO Valuation

Market Cap

366.7M

Price/Earnings (Trailing)

28.68

Price/Sales (Trailing)

0.59

EV/EBITDA

8.93

Price/Free Cashflow

-5.11

DCGO Price/Sales (Trailing)

DCGO Profitability

EBT Margin

2.61%

Return on Equity

4.25%

Return on Assets

2.61%

Free Cashflow Yield

-19.58%

DCGO Fundamentals

DCGO Revenue

Revenue (TTM)

624.3M

Rev. Growth (Yr)

83.16%

Rev. Growth (Qtr)

6.8%

DCGO Earnings

Earnings (TTM)

12.8M

Earnings Growth (Yr)

-72.1%

Earnings Growth (Qtr)

13.49%

Breaking Down DCGO Revenue

Last 7 days

7.4%

Last 30 days

-9.3%

Last 90 days

-2.5%

Trailing 12 Months

-57.5%

How does DCGO drawdown profile look like?

DCGO Financial Health

Current Ratio

1.99

DCGO Investor Care

Shares Dilution (1Y)

1.04%

Diluted EPS (TTM)

0.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	435.6M	451.6M	533.8M	624.3M
2022	387.1M	434.4M	452.9M	440.5M
2021	150.3M	206.5M	262.7M	318.9M
2020	0	0	0	94.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of DocGo Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 19, 2024	bienstock lee	sold (taxes)	-20,945	5.59	-3,747	chief executive officer
Mar 15, 2024	sugrue stephen	acquired	-	-	68,306	chief compliance officer
Mar 15, 2024	vashovsky stanley	acquired	-	-	21,721	-
Mar 15, 2024	rosenberg norman	acquired	-	-	133,197	cfo and treasurer
Mar 15, 2024	bienstock lee	acquired	-	-	218,579	chief executive officer
Mar 15, 2024	katz steven	bought	49,140	3.64	13,500	-
Mar 14, 2024	rosenberg norman	bought	36,100	3.61	10,000	cfo and treasurer
Mar 14, 2024	burdiek michael j	bought	36,100	3.61	10,000	-
Dec 15, 2023	burdiek michael j	acquired	-	-	23,088	-
Dec 15, 2023	travers james m	acquired	-	-	23,088	-

Which funds bought or sold DCGO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-75.02	-52,000	11,000	-%
Apr 23, 2024	ForthRight Wealth Management, LLC	unchanged	-	-418,325	1,090,340	0.39%
Apr 22, 2024	Rockwood Wealth Management, LLC	unchanged	-	-45,061	116,180	0.01%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	11,512	247,503	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	reduced	-38.18	-554,230	447,543	-%
Apr 19, 2024	Westside Investment Management, Inc.	unchanged	-	-1,163	3,030	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	sold off	-100	-120,995	-	-%
Apr 17, 2024	Iron Horse Wealth Management, LLC	unchanged	-	-293	764	-%
Apr 16, 2024	Pasadena Private Wealth, LLC	added	363	1,120,900	1,597,770	0.37%
Apr 12, 2024	Riverview Trust Co	new	-	20,337	20,337	0.02%

Are Funds Buying or Selling DCGO?

Are funds buying DCGO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DCGO

No. of Funds

DCGO Alerts

2 major insider buys recently.

Unveiling DocGo Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 01, 2024	hood river capital management llc	1.70%	1,774,198	SC 13G/A
Feb 14, 2024	hood river capital management llc	5.87%	6,103,476	SC 13G/A
Feb 12, 2024	flynn james e	5.12%	5,320,139	SC 13G/A
Jan 29, 2024	blackrock inc.	6.3%	6,507,898	SC 13G/A
Oct 18, 2023	flynn james e	5.80%	6,014,750	SC 13G
Feb 14, 2023	moore capital management, lp	0.5%	5e+05	SC 13G/A
Feb 03, 2023	blackrock inc.	5.5%	5,670,275	SC 13G
Jan 25, 2023	hood river capital management llc	5.42%	5,573,207	SC 13G
Feb 14, 2022	radcliffe capital management, l.p.	0%	0	SC 13G/A
Feb 14, 2022	moore capital management, lp	0.5%	5e+05	SC 13G/A

Recent SEC filings of DocGo Inc.

View All Filings

Date Filed	Form Type	Document
Apr 10, 2024	8-K	Current Report
Mar 21, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 14, 2024	4	Insider Trading
Mar 08, 2024	8-K	Current Report
Mar 01, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to DocGo Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-12.72%	-6.73%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-3.19%	11.59%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-0.12%	51.97%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.62%	17.22%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.26	4.12	6.06%	9.17%
ACHC	6.6B	2.9B	-7.52%	-4.24%	-303.27	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.76	0.42	6.74%	20.73%
BEAT	54.0M	-	-3.27%	-3.72%	-3.69	-	-	-12.94%
AMS	18.7M	21.3M	13.26%	5.28%	35.15	0.88	8.00%	-62.25%

DocGo Inc. News

Latest updates

DocGo Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)													(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Revenue	6.8%	199,246	186,553	125,487	113,003	108,785	104,320	109,519	117,892	121,164	85,839	62,186	49,689	-
Operating Expenses	5.5%	187,573	177,845	123,911	119,905	108,705	100,121	102,062	107,797	105,711	84,320	61,927	51,563	3,176
S&GA Expenses	-87.3%	204	1,606	685	307	2,406	91.00	1,000	1,258	1,730	994	1,189	843	534
R&D Expenses	-1.5%	3,185	3,235	2,574	1,864	1,722	1,373	1,148	1,142	1,285	855	665	569	725
EBITDA Margin	51.7%	0.06*	0.04*	0.03*	0.05*	0.08*	0.12*	0.12*	0.10*	0.08*	0.00*	-0.03*	-0.05*	-0.10*
Interest Expenses	-98.0%	7.00	346	522	809	466	334	98.00	-135	-262	-255	-130	-115	-130
Income Taxes	-51.2%	2,210	4,527	-355	-2,129	341	402	322	440	2.00	605	-1.11	10.00	164
Earnings Before Taxes	33.2%	12,196	9,157	989	-6,048	-1,976	2,868	12,078	9,813	20,277	1,406	101	-1,988	-8,104
EBT Margin	557.1%	0.03*	0.00*	-0.01*	0.02*	0.05*	0.10*	0.10*	0.08*	0.06*	-0.03*	-0.06*	-0.10*	-0.16*
Net Income	13.5%	5,255	4,630	3,355	-453	18,831	2,466	-979	-1,257	18,613	802	1,748	-320	-4,392
Net Income Margin	-58.5%	0.02*	0.05*	0.06*	0.05*	0.05*	0.05*	0.05*	0.06*	0.08*	-0.01*	-0.01*	-0.04*	-0.13*
Free Cashflow	80.4%	-9,142	-46,679	9,110	-25,094	-9,941	6,368	11,583	17,662	-10,783	7,755	-1,582	-2,144	-2,934

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Assets	16.8%	490	420	390	408	393	356	332	325	310	115	115	116	100	99.00	98.00	101
Current Assets	26.8%	339	267	234	258	271	252	276	268	256	0.00	0.00	1.00	1.00	0.00	-	59.00
Cash Equivalents	12.0%	59.00	53.00	109	120	157	170	198	199	176	43.00	37.00	31.00	34.00	0.00	46.00	52.00
Net PPE	-23.0%	17.00	22.00	22.00	22.00	21.00	18.00	12.00	13.00	13.00	10.00	10.00	-	9.00	-	-	6.00
Goodwill	-0.1%	48.00	48.00	48.00	48.00	39.00	35.00	9.00	9.00	9.00	7.00	7.00	-	7.00	-	-	6.00
Liabilities	44.5%	185	128	106	124	114	85.00	77.00	85.00	83.00	13.00	14.00	11.00	33.00	-	-	22.00
Current Liabilities	50.5%	170	113	92.00	109	100	71.00	58.00	61.00	58.00	0.00	0.00	0.00	23.00	0.00	-	10.00
Shareholder's Equity	4.6%	301	288	284	284	273	271	254	240	227	67.00	66.00	66.00	67.00	0.00	74.00	79.00
Retained Earnings	26.1%	-21.39	-28.96	-33.73	-32.37	-28.97	-37.04	-40.19	-52.93	-63.56	-12.67	-5.28	-2.23	-87.30	0.00	-	-72.94
Additional Paid-In Capital	1.6%	321	316	312	310	301	302	287	285	283	143	10.00	7.00	142	0.00	-	142
Shares Outstanding	0.2%	104	104	104	103	102	99.00	99.00	100	80.00	58.00	-	58.00	76.00	-	-	-
Minority Interest	10.7%	4.00	4.00	4.00	-	6.00	7.00	7.00	8.00	7.00	11.00	14.00	-	12.00	-	-	11.00
Float	-	-	-	861	-	-	-	616	-	-	-	114	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Cashflow From Operations	87.1%	-5,918	-45,878	10,693	-23,117	-8,737	7,421	11,922	18,265	-8,800	7,998	239	-1,384	-1,477	-2.06	-	-
Share Based Compensation	72.8%	5,807	3,361	-	-	3,439	1,111	-	-	-	-	-	-	-	-	-	-
Cashflow From Investing	-97.2%	-2,962	-1,501	-23,727	-1,689	-654	-35,835	-821	-1,137	-4,141	-848	-2,323	-1,276	-1,444	-1,364	-	-
Cashflow From Financing	249.7%	12,977	-8,667	8,760	-11,951	-6,865	-436	-1,374	2,497	149,079	-920	7,599	-550	57,771	4.00	-	-
Buy Backs	-	-	-	-	-	3,234	-140*	498	-	-	-	-	-	-	-	-	-

DCGO Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Income - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues, net	$ 624,288,642	$ 440,515,746	$ 318,718,580
Expenses:
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)	428,906,225	285,794,520	208,971,062
Operating expenses:
General and administrative	137,152,512	103,403,416	74,892,828
Depreciation and amortization	16,431,892	10,565,578	7,511,579
Legal and regulatory	13,082,569	8,780,590	3,907,660
Technology and development	10,858,724	5,384,853	3,320,183
Sales, advertising and marketing	2,801,740	4,755,161	4,757,970
Total expenses	609,233,662	418,684,118	303,361,282
Income from operations	15,054,980	21,831,628	15,357,298
Other income:
Interest income (expense), net	1,684,399	762,685	(763,030)
Gain on remeasurement of warrant liabilities	0	1,127,388	5,199,496
Change in fair value of contingent liability	1,437,525	0	0
(Loss) gain on equity method investments	(343,336)	8,919	(66,818)
(Loss) gain on remeasurement of operating and finance leases	(866)	1,388,273	0
Gain on bargain purchase	0	1,593,612	0
Gain from PPP loan forgiveness	0	0	142,667
Loss on disposal of fixed assets	(852,544)	(21,173)	(34,342)
Goodwill impairment	0	(2,921,958)	0
Other expense	(686,865)	(987,482)	(40,086)
Total other income	1,238,313	950,264	4,437,887
Net income before (provision for) benefit from income tax	16,293,293	22,781,892	19,795,185
(Provision for) benefit from income taxes	(6,244,965)	7,961,321	(615,697)
Net income	10,048,328	30,743,213	19,179,488
Net income (loss) attributable to noncontrolling interests	3,189,873	(3,841,285)	(4,564,270)
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	6,858,455	34,584,498	23,743,758
Other comprehensive income
Foreign currency translation adjustment	743,699	773,707	16,038
Total comprehensive income	$ 7,602,154	$ 35,358,205	$ 23,759,796
Net income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share)	$ 0.07	$ 0.34	$ 0.30
Weighted-average shares outstanding - Basic (in Shares)	103,511,299	101,228,369	80,293,959
Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share)	$ 0.06	$ 0.34	$ 0.25
Weighted-average shares outstanding - Diluted (in Shares)	105,617,817	102,975,831	94,863,613

DCGO Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 59,286,147	$ 157,335,323
Accounts receivable, net of allowance of $6,276,454 and $7,818,702 as of December 31, 2023 and December 31, 2022, respectively	262,083,462	102,995,397
Assets held for sale	0	4,480,344
Prepaid expenses and other current assets	17,499,953	6,269,841
Total current assets	338,869,562	271,080,905
Property and equipment, net	16,835,484	21,258,175
Intangibles, net	37,682,928	22,969,246
Goodwill	47,539,929	38,900,413
Restricted cash	12,931,839	6,773,751
Operating lease right-of-use assets	9,580,535	9,074,277
Lease right-of-use assets	12,003,919	9,039,663
Equity method investments	553,573	597,977
Deferred tax assets	11,888,539	9,957,967
Other assets	2,565,649	3,625,254
Total assets	490,451,957	393,277,628
Current liabilities:
Accounts payable	19,827,258	21,582,866
Accrued liabilities	91,340,609	31,573,031
Line of credit	25,000,000	0
Notes payable, current	28,131	664,913
Due to seller	7,823,009	26,244,133
Contingent consideration	19,792,982	10,555,540
Operating lease liability, current	2,773,020	2,325,024
Liabilities held for sale	0	4,480,344
Finance lease liability, current	3,534,073	2,732,639
Total current liabilities	170,119,082	100,158,490
Notes payable, non-current	41,586	1,236,601
Operating lease liability, non-current	7,223,941	7,040,982
Finance lease liability, non-current	7,896,392	5,914,164
Total liabilities	185,281,001	114,350,237
Commitments and contingencies
Stockholders’ equity:
Common stock ($0.0001 par value; 500,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 104,055,168 and 102,411,162 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively)	10,406	10,241
Additional paid-in-capital	320,693,866	301,451,435
Accumulated deficit	(21,394,310)	(28,972,216)
Accumulated other comprehensive income	1,484,905	741,206
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries	300,794,867	273,230,666
Noncontrolling interests	4,376,089	5,696,725
Total stockholders’ equity	305,170,956	278,927,391
Total liabilities and stockholders’ equity	$ 490,451,957	$ 393,277,628

About DocGo Inc.

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; testing; vaccinations; and event services, which include on-site healthcare support at sporting events and concerts. DocGo Inc. was incorporated in 2015 and is based in New York, New York.

WEBSITE	docgo.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2064

DocGo Inc. Frequently Asked Questions

What is the ticker symbol for DocGo Inc.? What does DCGO stand for in stocks?

DCGO is the stock ticker symbol of DocGo Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DocGo Inc. (DCGO)?

As of Tue Apr 23 2024, market cap of DocGo Inc. is 364.6 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DCGO stock?

You can check DCGO's fair value in chart for subscribers.

What is the fair value of DCGO stock?

You can check DCGO's fair value in chart for subscribers. The fair value of DocGo Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DocGo Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DCGO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DocGo Inc. a good stock to buy?

The fair value guage provides a quick view whether DCGO is over valued or under valued. Whether DocGo Inc. is cheap or expensive depends on the assumptions which impact DocGo Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DCGO.

What is DocGo Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, DCGO's PE ratio (Price to Earnings) is 28.51 and Price to Sales (PS) ratio is 0.58. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DCGO PE ratio will change depending on the future growth rate expectations of investors.